GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Synergy CHC Corp (OTCPK:SNYR) » Definitions » EV-to-EBITDA

Synergy CHC (Synergy CHC) EV-to-EBITDA : -0.72 (As of May. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synergy CHC EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Synergy CHC's enterprise value is $5.98 Mil. Synergy CHC's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was $-8.26 Mil. Therefore, Synergy CHC's EV-to-EBITDA for today is -0.72.

The historical rank and industry rank for Synergy CHC's EV-to-EBITDA or its related term are showing as below:

SNYR's EV-to-EBITDA is not ranked *
in the Medical Distribution industry.
Industry Median: 9.7
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Synergy CHC's stock price is $0.01. Synergy CHC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was $-0.112. Therefore, Synergy CHC's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Synergy CHC EV-to-EBITDA Historical Data

The historical data trend for Synergy CHC's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy CHC EV-to-EBITDA Chart

Synergy CHC Annual Data
Trend Jul12 Jul13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBITDA
Get a 7-Day Free Trial -11.15 11.14 15.32 -6.54 -1.57

Synergy CHC Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.71 -22.31 -12.78 -1.57 -

Competitive Comparison of Synergy CHC's EV-to-EBITDA

For the Medical Distribution subindustry, Synergy CHC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synergy CHC's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Synergy CHC's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Synergy CHC's EV-to-EBITDA falls into.



Synergy CHC EV-to-EBITDA Calculation

Synergy CHC's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5.980/-8.257
=-0.72

Synergy CHC's current Enterprise Value is $5.98 Mil.
Synergy CHC's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synergy CHC  (OTCPK:SNYR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Synergy CHC's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.01/-0.112
=At Loss

Synergy CHC's share price for today is $0.01.
Synergy CHC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.112.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Synergy CHC EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Synergy CHC's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy CHC (Synergy CHC) Business Description

Traded in Other Exchanges
N/A
Address
865 Spring Street, Westbrook, ME, USA, 04092
Synergy CHC Corp is a consumer health care company. It is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Synergy generates the majority of its revenue from the sale of Flat Tummy Tea, which is exclusively sold online at www.flattummyco.com. Flat Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce bloating.
Executives
Jack Ross director, 10 percent owner, officer: President, CEO and CFO 3435 OCEAN PARK BLVD. #107 SANTA MONICA CA 90405
Patrick S. Mccullough officer: President C/O SYNERGY CHC CORP. 865 SPRING STREET WESTBROOK ME 04092
Jeffrey Kadanoff officer: Chief Financial Officer C/O SYNERGY CHC CORP. 865 SPRING STREET WESTBOOK ME 04902
Gale K. Bensussen director C/O SYNERGY CHC CORP. 865 SPRING STREET WESTBROOK ME 04092
Knight Therapeutics (barbados) Inc. 10 percent owner CHANCERY HOUSE HIGH STREET BRIDGETOWN C8 BB11128
Stephen J Fryer director
James Paul Sorelle director 3435 OCEAN PARK BLVD #107 SANTA MONICA CA 90405
Gowan Private Equity Inc. 10 percent owner 275 CANTERBURY LANE FALL RIVER A5 B2T1A4

Synergy CHC (Synergy CHC) Headlines

From GuruFocus

Synergy CHC Corp. Announces First Quarter 2019 Results

By Marketwired Marketwired 05-03-2019

Synergy CHC Corp. Announces Fiscal 2019 Year End Results

By Marketwired Marketwired 04-30-2020

Synergy CHC Corp. Announces Third Quarter 2019 Results

By Marketwired Marketwired 11-14-2019

Synergy CHC Corp. Announces Second Quarter 2019 Results

By Marketwired Marketwired 08-14-2019

Synergy CHC Corp. Announces Insider Buying

By Marketwired Marketwired 12-10-2018

Synergy CHC Corp. Announces First Quarter 2020 Results

By Marketwired Marketwired 06-29-2020

Synergy CHC Corp. Announces Third Quarter 2018 Results

By Marketwired Marketwired 11-13-2018